This meeting will highlight the contributions of biophysics to the understanding, diagnosis and treatment of infectious diseases, with particular focus on TB, malaria and HIV/AIDS, and the development of innovative therapies for these diseases. Many of the meeting contributions will focus on structural biology, molecular modelling, spectroscopy, and high resolution optical techniques but abstract submissions of work highlighting biophysics of any kind that contributes to our understanding of these diseases are highly encouraged. Topics in infectious disease that would be of interest to biophysicists are also welcomed.
The details are:
Biophysics in the Understanding, Diagnosis and Treatment of Infectious Diseases
Stellenbosch (South Africa), November 16 - 20, 2015
http://www.biophysics.org/2015southafrica
The invited speakers include:
- Mario Amzel, Johns Hopkins University School of Medicine, USA
- Cheryl Arrowsmith, University of Toronto, Canada
- Frederick Balagaddé, KwaZulu-Natal Research Institute for Tuberculosis and HIV (K-RITH), South Africa
- Jonathan Blackburn, University of Cape Town, South Africa
- Tom Blundell, University of Cambridge, United Kingdom
- Edward Egelman, University of Virginia, USA
- Sarah Fortune, Harvard University, USA
- Musa Mhlanga, Council for Scientific and Industrial Research (CSIR), South Africa
- Valerie Mizrahi, Institute of Infectious Disease & Molecular Medicine (IDM), South Africa
- Pradipsinh Rathod, University of Washington, USA
- Stefan Raunser, Max Planck Institute of Molecular Biology, Germany
- James Sacchettini, Texas A&M University, USA
- Helen R. Saibil, Birkbeck, University of London, United Kingdom
- Erica Ollmann Saphire, The Scripps Research Institute, USA
- Wolf-Dieter Schubert, University of Pretoria, South Africa
- Bryan Trevor Sewell, University of Cape Town, South Africa
- Alex Sigal, KwaZulu-Natal Research Institute for Tuberculosis and HIV (K-RITH), South Africa
- Michael Starnbach, Harvard Medical School, USA
- Adrie Steyn, KwaZulu-Natal Research Institute for Tuberculosis and HIV (K-RITH), South Africa
- Robert Stroud, University of California San Francisco, USA
- David Stuart, University of Oxford, United Kingdom
- Sriram Subramaniam, NIH NCI, USA
- Frank von Delft, University of Oxford, United Kingdom
- Gabriel Waksman, University College London & Birkbeck, University of London, United Kingdom
- Tim Wells, Medicines for Malaria Venture, Switzerland
- Robin Wood, Desmond Tutu HIV Centre (UCT), South Africa
- Peijun Zhang, University of Pittsburgh School of Medicine, USA
